Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunologic Profile of Chronically Photodamaged Skin
NCT02889159Phase 1Completed
- Sponsor
- University of Michigan
- Start
- Jun 2016
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Phase 1, open-label trial (5 arms), sponsored by University of Michigan. Primary endpoints: Erythema in photodamaged and photoprotected skin at 5 days, Human Beta Defensin 2 (DEFB4) Fold Change at 5 days and 1 more. Started Jun 2016; status: completed.
Beyond the preview
Go deeper on NCT02889159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02889159.